


Biologics in Rheumatology: Revolution & Perspectives

Biologic Treatment Recommendations for Rheumatic Disease Patients Who Contract COVID-19
Biologic Spending & Price Trends

Investigators Assess Infection Risk with RA Biologics

Ustekinumab Has Longer Efficacy Duration than TNFIs for Plaque Psoriasis
When Starting Biologics for RA, Disease Severity Predicts Likelihood of Remission
